Management Team

Kleber Gallardo, Founder and CEO

describe the imagePreviously Kleber was a founder and CTO of Bonaire Software Solutions, LLC, which is now a leading provider of Revenue Management Systems to the financial market. The company grew from a small initial investment to the sale of a significant portion of the business to Kayne Anderson, a private equity firm. As CTO he provided technical consulting services to large financial institutions. He developed a number of revenue management products including REVPORT, a product suite deployed around the globe by many of the top 20 largest money managers with a total "funds under management" in excess of 4 trillion US$.

Prior to Bonaire, Kleber was Vice President of Technology State Street's Financial Markets Group where he deployed real-time, high availability technology platforms such as: foreign exchange, money markets, securities lending and trade banking. He managed the deployment of these applications in major financial centers around the world. He has extensive technical expertise in software architectures, object technology, internet-based applications, component based software design, real-time systems and high availability large scale distributed systems. Kleber is a Cum Laude graduate of Polytechnic. He has a master in robotics from Massachusetts Institute of Technology. He also holds engineering degrees in Neural Networks and Robotics from Columbia University and a Managment degree from Harvard Extension School.

Paul McLaughlin, CSO

Paul McLaughlin is the Chief Strategy Officer for Alivia Technology. He is responsible for identifying new markets for the Absolute Insight Product Suite in addition to identifying new uses and functionality for the existing product. Prior to joining Alivia Technology Paul served as the CIO and Director of Information Technology for the Massachusetts Office of the State Auditor. He held this position for twenty years. Paul has a B.A. in Economics and an MBA, both from University of Massachusetts Boston. His thirty-five year career includes extensive experience in both the public and private sectors. Prior to 1996, Paul’s focus was accounting and finance. For nine years he was a principal in a mid-size public accounting firm, Mullen and Company, where his area of specialization was the reimbursement issues of not-for-profit organizations. The balance of Paul’s career has been in government and has included employment at the City of Boston Treasury, The Commonwealth of Massachusetts Rate Setting Commission where he developed an expertise in the oversight of human services vendors.

While serving as CIO of the State Auditor’s Office, Paul has overseen a number of large IT Projects. An area of primary interest to Paul is the use of data analytics, business intelligence and the predictive modeling in the identification and isolation of risk, fraud, and abuse in the audit and management processes.

ML Ujwal, Chief Data Scientist

ML Ujwal is a PhD with decades of experience in the areas of Informatics related biological data mining and visualization and has a strong pedigree is science, and is associated with the pharmaceutical/biotech/healthcare industry.

 At Eli Lilly & Co, he led a group in Discovery Informatics to drive pharmaceutical drug discovery and drug development. The group is engaged in data mining efforts using in-silico and machine learning techniques, in the early phase of drug discovery.

Prior to joining Eli Lilly & Co, he was on the faculty of Rabb School of Informatics, Brandeis University, Boston. In the capacity of the chair of the program, he was instrumental in shaping the core curriculum, providing the strategic leadership and teaching.

 Earlier to his Brandeis stint, he was with AnVil Informatics, Burlington, MA., a venture-funded informatics start-up and was one of the initial leaders. He was also associated with the institute of Genomic Research (TIGR), Rockville, MD, as staff scientist. His academic credentials include post-doctoral research at Dept. of Molecular Biophysics and Biochemistry, Yale University and Laboratory of Membrane Biophysics at Harvard.